# US 2004/0023953 A1 · Tricylic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (MMP) inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0023953 A1
- Document ID: US20040023953A1
- Status: Published application
- Kind: A1
- Application number: 10/381,024
- Filed: 2003-07-30
- Published: 2004-02-05
- Earliest claimed: 2000-09-21
- Inventors: Uwe Kausmeier; Jochen Heinicke; Christoph Arkona
- Web page: https://patentgrep.com/patent/US20040023953A1

## CPC

- C07D 513/04: Ortho-condensed systems
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to mercaptomethyl-substituted thiazolo[2,3-b]quinazolines, oxazolo[2,3-b]quinazolines and imidazolo[2,1-b]quinazolines. It is the object of the invention to discover new matrix metalloproteinase inhibitors (MMP) and give a simple synthesis method. The object is achieved by the production of the indicated compounds. By means of them it is possible to achieve progress using them as active substances in pharmaceutical preparations for treating diseases such as inflammatory responses of non-specific causes, sunburn and allergies.

## Claims

### Claim 1

Thiazolo(2,3-b]quinazolinones, oxazolo[2,3-b]-quinazolinones, imidazo[2,1-b]quinazolinones of general formulae Ia and Ib
3
wherein
R1=H, methyl, methoxy, dimethoxy, Hal (Hal=F, Cl, Br), carboxy,
R2, R3, R4=hydrogen, methyl
X=carbonyl, sulfonyl,
Y S, O, NH
and the tautomers and salts thereof.

### Claim 2 (depends on 1)

A method of producing the compounds according to claim 1,
characterized in that:
compounds of general formulae IIa and IIb
4
wherein
R1=H, methyl, methoxy, dimethoxy, Hal (Hal=F, Cl, Br), carboxy
R2, R3, R4=hydrogen, methyl
X=carbonyl, sulfonyl
Y=S, O, NH
Z=Cl, Br, J, tosyl
are reacted with a sulfur-transmitting agents in an inert solvent,
the resulting product is isolated
and the desired end product is obtained by subsequent mild saponification

### Claim 3 (depends on 2)

The method according to claim 2, characterized in that thiourea or xanthogenates are user as sulfur-transmitting agent.

### Claim 4 (depends on 1)

Use or compounds according to claim 1 as matrix metalloproteinase inhibitors.

### Claim 5 (depends on 1)

Pharmaceutical composition, containing compounds according to claim 1.
